Nisa Investment Advisors
NRIX icon

Nisa Investment Advisors’s Nurix Therapeutics NRIX Stock Holding History

Nisa Investment Advisors’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.9K Buy
3,788
+1,232
+48% +$21K ﹤0.01% 1593
2026
Q1 		$39.6K Buy
2,556
+1,830
+252% +$30.3K ﹤0.01% 1769
2025
Q4 		$13.8K Buy
726
+127
+21% +$1.82K ﹤0.01% 2092
2025
Q3 		$5.54K Sell
599
-96
-14% -$997 ﹤0.01% 2419
2025
Q2 		$7.92K Buy
695
+96
+16% +$1.04K ﹤0.01% 2353
2025
Q1 		$7.12K Sell
599
-24
-4% -$401 ﹤0.01% 2178
2024
Q4 		$11.7K Sell
623
-59
-9% -$1.35K ﹤0.01% 2092
2024
Q3 		$15.3K Buy
682
+59
+9% +$1.34K ﹤0.01% 1990
2024
Q2 		$13K Buy
623
+524
+529% +$8.16K ﹤0.01% 2070
2024
Q1 		$1.46K Buy
99
+74
+296% +$796 ﹤0.01% 2289
2023
Q4 		$258 Sell
25
-1,240
-98% -$8.5K ﹤0.01% 2518
2023
Q3 		$9.94K Buy
1,265
+1,221
+2,775% +$11.1K ﹤0.01% 2179
2023
Q2 		$440 Buy
+44
New +$449 ﹤0.01% 2584
2023
Q1 		– Sell
-2,250
Closed -$25K – 2639
2022
Q4 		$25K Hold
2,250
– – ﹤0.01% 1997
2022
Q3 		$29K Buy
2,250
+50
+2% +$791 ﹤0.01% 1943
2022
Q2 		$28K Sell
2,200
-20,600
-90% -$233K ﹤0.01% 1940
2022
Q1 		$319K Buy
+22,800
New +$405K ﹤0.01% 1214

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WFA
WestHill Financial Advisors San Rafael, California $587M AUM 20.13% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Nisa Investment Advisors's NRIX Position: Q2 2026 in Review

Nisa Investment Advisors increased its Nurix Therapeutics (NRIX) stake by 48% in Q2 2026, buying an estimated $21K and bringing the position to 3,788 shares worth $91.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

Nisa Investment Advisors first reported a position in NRIX in Q1 2022 and has held it in 17 quarters since. The position peaked at $319K in Q1 2022. 68 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Nisa Investment Advisors held 3,788 shares of Nurix Therapeutics worth $91.9K as of Q2 2026.
  • Nisa Investment Advisors bought 1,232 Nurix Therapeutics shares in Q2 2026, an estimated $21K.
  • Nurix Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1593 holding.
  • Nisa Investment Advisors first reported a position in Nurix Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Nisa Investment Advisors's Nurix Therapeutics position peaked at $319K in Q1 2022.
  • 68 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.